Evidence-Based Reviews

When a disaster disrupts access to psychiatric medications

Author and Disclosure Information

 

References

Contingency planning should be a part of the treatment plan for every patient receiving chronic opioid therapy who lives in an area where major disasters are likely to occur.

Medication-assisted treatment for opioid use disorder. Patients receiving treatment for opioid use disorder may be prescribed the partial opioid agonist buprenorphine, either by itself or in combination with the opioid antagonist naloxone. This could be particularly problematic to continue in a major disaster due to the lack of credentialed clinicians, limited supplies, and patients only receiving small amounts of the medication at a time due to the risk of diversion.

Symptoms of buprenorphine withdrawal are similar to those associated with opioid withdrawal. Developing a thoughtful plan in case of a disaster should be part of all buprenorphine prescribing. Patients should be aware of withdrawal symptoms and what to do if they run out of medication.

Additionally, emergency clinicians should have access to buprenorphine and buprenorphine/naloxone and the ability to prescribe them in disaster situations. As with all aspects of disaster response, it is wise to work out issues in advance.

Help your patients get ready

Advise your patients to prepare emergency kits that contain their psychiatric medications that they could quickly grab and go if needed. Because there may be times when it is not possible to gather all necessary medications, having even a small supply ready to go at a moment’s notice would be beneficial. If permitted, patients should also consider keeping medications in multiple locations, including at their place of work, home, or a family member’s home.

Continue to: Additionally, instruct patients...

Pages

Recommended Reading

Malpractice: More lawsuits does not equal more relocations
MDedge Psychiatry
ONC’s Dr. Rucker: Era of provider-controlled data is over
MDedge Psychiatry
MedPAC to begin work on Part D redesign
MDedge Psychiatry
Proportion of women speaking at medical conferences rises over decade
MDedge Psychiatry
As Sanders officially revives Medicare-for-all, Plan B for Democrats gains traction
MDedge Psychiatry
Cost gap widens between brand-name, generic drugs
MDedge Psychiatry
How to incorporate the gender wage gap into contract negotiations
MDedge Psychiatry
CMS plan will incentivize generic drug use
MDedge Psychiatry
Patients say primary care video visits are convenient, high quality
MDedge Psychiatry
Pretrial screening panels: Do they reduce frivolous claims?
MDedge Psychiatry